Patent · US Active

Polypeptide conjugates and methods of uses

US11529394B2 · kind B2 · utility

1Cited by
44References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 27, 2021
Grant dateDec 20, 2022
Priority date
Expiry dateDec 27, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a polypeptide conjugates comprising GLP-1 receptor agonist and a peptide linker, and pharmaceutical compositions comprising the same. Methods of using such for treating diseases are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.